CHU - Hôpitaux de Rouen Company Profile

05:54 EDT 24th May 2016 | BioPortfolio



1 rue de Germont


Phone: 02 32 88 89 90

News Articles [12 Associated News Articles listed on BioPortfolio]

BRIEF-Medtech announces new sale of ROSA in France

* Sale is to the CHU de Rouen Source text: Further company coverage: (Gdynia Newsroom)

The Lancet: Doctors give chilling account of treating casualties of Paris terrorist attacks

(The Lancet) In a Viewpoint published in The Lancet today, a group of doctors from the Assistance Publique-Hôpitaux de Paris describe in chilling detail how they coped with the large influx of wounde...

Doctors give chilling account of treating casualties of Paris terrorist attacks

In a Viewpoint published in The Lancet today, a group of doctors from the Assistance Publique-Hôpitaux de Paris (APHP) describe in chilling detail how they coped with the large influx of wounded on t...

CANCER de la PROSTATE avancé: Une nouvelle combinaison thérapeutique prometteuse - UdeM

C'est une nouvelle combinaison médicamenteuse prometteuse contre le cancer de la prostate avancé, testée par une équipe de l'Université de Montréal, qui s'av&...

AMLYLOSE HÉRÉDITAIRE: Découverte d'une nouvelle mutation responsable - Nature Communications

La découverte d'une nouvelle mutation responsable d'amylose héréditaire, par une équipe de l'Assistance publique des Hôpitaux de Marseille (AP-HM) apporte un grand es...

Study demonstrates possibility of changing behavior of gaze by transcranial magnetic stimulation

A study financed by the Assistance Publique-Hôpitaux de Paris has been conducted under the direction of Monica Zilbovicius in the Inserm Unit 1000 on a particular region of the brain, the superior te...

VIH-Sida: Tat Oyi, le candidat vaccin prometteur testé à Marseille - Retrovirology

Ce candidat vaccin anti-VIH, à l'étude depuis plusieurs années semble avoir trouvé sa dose optimale grâce aux travaux de cette équipe de l'Assistance Publique ...

CYBERTHÉRAPIE: Vaincre ses peurs grâce à la réalité virtuelle - CHU Réseau

L'utilisation de la réalité virtuelle a fait ses preuves dans le traitement de troubles mentaux telles l'anxiété et les phobies mais qu'en est-il pour la peur des hauteurs ...

Drugs and Medications [0 Results]


PubMed Articles [3 Associated PubMed Articles listed on BioPortfolio]

Evaluation of excreta management in a large French multi-hospital institution.

Excreta are a major source of multidrug-resistant Enterobacteriaceae including strains that produce extended-spectrum beta-lactamase (ESBL). The increase of ESBL incidence in Assistance Publique - Hô...

Multicentric evaluation of eight glucose and four ketone blood meters.

A) OBJECTIVES: High precision meters for blood glycemia are mandatory for monitoring glucose status in patients, avoiding both hypo- and hyper-glycemia. Health care providers routinely used in both ou...

Is the introduction of innovative methods in cardiovascular diagnostics and therapy to quick?

Andreas Grüntzig can be regarded as the pioneer of modern cardiology. Based on the previous experiences of Charles Dotter in Portland, Oregon, and after many years of preparation as a young 38-year-o...

Clinical Trials [7 Associated Clinical Trials listed on BioPortfolio]

Effects of Substance P Antagonists on Adrenal Secretion

Data from the literature and previous in vitro research conducted in the investigators' laboratory (INSERM U413/EA4310, University of Rouen) suggest that adrenal corticosteroid secretion m...

Biological Efficacy of Clopidogrel After Implantation of Drug-Eluting Stents (SPACE)

The risk of thrombotic complications after implantation of drug-eluting stents (DES) may be increased in patients with diabetes mellitus (DM) or metabolic syndrome (MS). It is recommended ...

CYTRAM (Cytochrome P450, Tramadol)

Many methods to detect CYP2D6 poor metabolizers have been validated. Some of them are based on phenotyping (metabolism of dextromethorphan or debrisoquine) and some others on genotyping. U...

Efficacy of Collagen-elastin Dermal Substitute in the Treatment of Loss of Cutaneous Substances With Skin Grafts

In reconstructive surgery , most losses of cutaneous substance require the use of a thin skin graft . This technique allows epidermization of the defect by applying a thin layer of autolog...

Aortic Cross-Clamping and Systemic Inflammatory Response in Humans: Effect of Ischemic Preconditioning

Multiple organ dysfunction syndrome is a major cause of morbidity and mortality after abdominal aortic aneurysm (AAA) surgery. It is postulated that aortic cross-clamping during open AAA r...

Companies [8 Associated Companies listed on BioPortfolio]

CHU - Hôpitaux de Rouen


Normandie Développement Rouen

An Internationally Renowned French and European Region! 3.2 million inhabitants, 5th biggest French economic region, 2nd largest region for industrial investments per capita, Number one French port c...

Université de Rouen



Founded in 2001, PROTEOMIC SOLUTIONS is a specialized protein lab service located between Paris and Rouen that conducts proteomic projects and practices recombinant protein technology, combined with e...

ANGANY Genetics

ANGANY Genetics is a biotechnology company specialising in the development and production of high quality recombinant allergens for the diagnosis and treatment of allergies. This ...

More Information about "CHU - Hôpitaux de Rouen" on BioPortfolio

We have published hundreds of CHU - Hôpitaux de Rouen news stories on BioPortfolio along with dozens of CHU - Hôpitaux de Rouen Clinical Trials and PubMed Articles about CHU - Hôpitaux de Rouen for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of CHU - Hôpitaux de Rouen Companies in our database. You can also find out about relevant CHU - Hôpitaux de Rouen Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks

Searches Linking to this Company Record